M&T Bank’s Zomedica Corp. ZOM Stock Holding History

M&T Bank’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-19,685	Closed	-$3.29K	–	1693
2023 Q3	$3.29K	Hold	19,685	–	–	﹤0.01%	1564
2023 Q2	$3.94K	Hold	19,685	–	–	﹤0.01%	1613
2023 Q1	$4.17K	Hold	19,685	–	–	﹤0.01%	1636
2022 Q4	$3.21K	Hold	19,685	–	–	﹤0.01%	1592
2022 Q3	$4K	Hold	19,685	–	–	﹤0.01%	1586
2022 Q2	$4K	Hold	19,685	–	–	﹤0.01%	1578
2022 Q1	$7K	Hold	19,685	–	–	﹤0.01%	1513
2021 Q4	$6K	Sell	19,685 -56,000	-74%	-$25.2K	﹤0.01%	1570
2021 Q3	$40K	Hold	75,685	–	–	﹤0.01%	1508
2021 Q2	$63K	Hold	75,685	–	–	﹤0.01%	1517
2021 Q1	$120K	Buy	75,685 +56,000	+284%	+$91.5K	﹤0.01%	1464
2020 Q4	$5K	Buy	+19,685	New	+$2.51K	﹤0.01%	1659

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

M&T Bank's ZOM Position: Q4 2023 in Review

M&T Bank sold out of Zomedica Corp. (ZOM) in Q4 2023, closing a stake of 19,685 shares — an estimated $3.29K sold.

M&T Bank first reported a position in ZOM in Q4 2020 and held it in 12 quarters. The position peaked at $120K in Q1 2021. 92 funds tracked by Wall St. Rank hold ZOM as of Q4 2023.

M&T Bank reported no remaining Zomedica Corp. position as of Q4 2023 after selling out during the quarter.
M&T Bank sold 19,685 Zomedica Corp. shares in Q4 2023, an estimated $3.29K.
M&T Bank first reported a position in Zomedica Corp. in Q4 2020 and held it in 12 quarters.
M&T Bank's Zomedica Corp. position peaked at $120K in Q1 2021.
92 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2023.

Based on M&T Bank's 13F filing for Q4 2023, filed 6 Feb 2024.